CLINICAL_TRIALS
trial_result
· 2013-03-13
Clinical Trial Update: Citalopram to Enhance Cognition in HD [Phase 2]
Summary
A Phase 2 trial tested citalopram for cognitive enhancement in Huntington's disease; the study has completed and results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Iowa | Conditions: Huntington Disease, Chorea | Phase 2 | Status: COMPLETED | Results posted: 2013-03-13